These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 8592949)

  • 1. Inhibition of antigen-presenting cell function by alendronate in vitro.
    Sansoni P; Passeri G; Fagnoni F; Mohagheghpour N; Snelli G; Brianti V; Engleman EG
    J Bone Miner Res; 1995 Nov; 10(11):1719-25. PubMed ID: 8592949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of inhibitory effects by murine interferon gamma and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK).
    Tohkin M; Kakudo S; Kasai H; Arita H
    Cancer Immunol Immunother; 1994 Sep; 39(3):155-60. PubMed ID: 7522963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of neridronate on axial involvement in patients with spondyloarthritis when biologics are not possible. Results of a monocentric study.
    Crotti C; Di Taranto R; Orsini F; Ferrito M; Varenna M; Favalli EG; Caporali R
    Front Med (Lausanne); 2023; 10():1282169. PubMed ID: 38076262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management.
    Fatica M; D'Antonio A; Novelli L; Triggianese P; Conigliaro P; Greco E; Bergamini A; Perricone C; Chimenti MS
    Curr Rheumatol Rep; 2023 Jan; 25(1):12-33. PubMed ID: 36308677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of m6A mediates tissue immune microenvironment in calcific aortic valve disease.
    Chen JY; Xiong T; Sun YR; Cong J; Gong JS; Peng L; Rong YW; Wang ZY; Chang Q
    Ann Transl Med; 2022 Sep; 10(17):931. PubMed ID: 36172101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial.
    Pawade TA; Doris MK; Bing R; White AC; Forsyth L; Evans E; Graham C; Williams MC; van Beek EJR; Fletcher A; Adamson PD; Andrews JPM; Cartlidge TRG; Jenkins WSA; Syed M; Fujisawa T; Lucatelli C; Fraser W; Ralston SH; Boon N; Prendergast B; Newby DE; Dweck MR
    Circulation; 2021 Jun; 143(25):2418-2427. PubMed ID: 33913339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of monocyte-macrophage inhibition by ibandronate on graft function and survival after kidney transplantation: a single-centre follow-up study over 15 years.
    Tillmann FP; Grotz W; Rump LC; Pisarski P
    Clin Exp Nephrol; 2018 Apr; 22(2):474-480. PubMed ID: 28856476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates Inhibit Pain, Bone Loss, and Inflammation in a Rat Tibia Fracture Model of Complex Regional Pain Syndrome.
    Wang L; Guo TZ; Hou S; Wei T; Li WW; Shi X; Clark JD; Kingery WS
    Anesth Analg; 2016 Oct; 123(4):1033-45. PubMed ID: 27636578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes as a risk factor for medication-related osteonecrosis of the jaw.
    Peer A; Khamaisi M
    J Dent Res; 2015 Feb; 94(2):252-60. PubMed ID: 25477311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate.
    Lopalco G; Rigante D; Vitale A; Frediani B; Iannone F; Cantarini L
    Clin Rheumatol; 2015 Apr; 34(4):807-9. PubMed ID: 24609716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly oral alendronate in mevalonate kinase deficiency.
    Cantarini L; Vitale A; Magnotti F; Lucherini OM; Caso F; Frediani B; Galeazzi M; Rigante D
    Orphanet J Rare Dis; 2013 Dec; 8():196. PubMed ID: 24360083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone vascularization in normal and disease conditions.
    Carulli C; Innocenti M; Brandi ML
    Front Endocrinol (Lausanne); 2013; 4():106. PubMed ID: 23986744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of efficacy of pamidronate in undifferentiated spondyloarthropathy (uSpA): a placebo control trial in a tertiary level center.
    Sarkar RN; Phaujdar S; De D; Bhattacharyya K
    Rheumatol Int; 2012 Dec; 32(12):3945-50. PubMed ID: 22200806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection, vascularization, remodelling--are stem cells the answers for bone diseases of the jaws?
    Handschel J; Meyer U
    Head Face Med; 2011 Feb; 7():5. PubMed ID: 21332971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do bisphosphonates and statins have a role in spondyloarthritis management?
    Maksymowych WP
    Curr Rheumatol Rep; 2008 Oct; 10(5):364-70. PubMed ID: 18817639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench.
    Allen MR
    Cells Tissues Organs; 2009; 189(1-4):289-94. PubMed ID: 18698128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation.
    Pettway GJ; Meganck JA; Koh AJ; Keller ET; Goldstein SA; McCauley LK
    Bone; 2008 Apr; 42(4):806-18. PubMed ID: 18234576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alendronate enhances antibiotic-impregnated bone grafts in the treatment of osteomyelitis.
    Ozturk AM; Tabak AY; Aktekin CN; Altay M; Erdemli E; Karahuseyinoglu S; Korkusuz F
    Int Orthop; 2008 Dec; 32(6):821-7. PubMed ID: 17611757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of ankylosing spondylitis: a systematic review.
    Boulos P; Dougados M; Macleod SM; Hunsche E
    Drugs; 2005; 65(15):2111-27. PubMed ID: 16225367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of interleukin-1 in the inflammatory actions of aminobisphosphonates in mice.
    Yamaguchi K; Motegi K; Iwakura Y; Endo Y
    Br J Pharmacol; 2000 Aug; 130(7):1646-54. PubMed ID: 10928970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.